Timing of Initiation of LMWH Administration in Pregnant Women With APS

Status Completed

Clinical Trial Summary

Evaluation of the effect of altering the timing of initiation of low molecular weight heparin (LMWH) administration on the pregnancy outcomes in women with antiphospholipid syndrome (APS)

Clinical Trial Description

Women will be randomly divided into two groups; one will start Enoxaparin therapy once positive pregnancy test is established and the other will start Enoxaparin therapy after sonographic confirmation of fetal cardiac pulsation. In all women, Enoxaparin will be given in a dose of 40 mg/day subcutaneously and the therapy will continue until termination of pregnancy ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02326051
Study type	Interventional
Source	Mansoura University
Contact
Status	Completed
Phase	Phase 4
Start date	December 2014
Completion date	May 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01475149` - Effect of HCQ on AnxA5 Resistance Assay in Antiphospholipid (aPL) Positive Patients With and Without Systemic Lupus Erythematosus (SLE)	N/A
Completed	`NCT00537290` - A Pilot Study of Rituximab for the Anticoagulation Resistant Manifestations of Antiphospholipid Syndrome	Phase 2
Recruiting	`NCT00616317` - Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study
Recruiting	`NCT00198068` - Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
Completed	`NCT00180817` - Longitudinal Study of the Clinical and Haematological Cause of Women With Antiphospholipid Antibodies.
Completed	`NCT03682419` - Evaluation of Precision and Accuracy of INR Measurements in a Point of Care Device (OPTIMAL)	N/A
Not yet recruiting	`NCT03303508` - Measurement of Anti-dsDNA by Both CLIFT & ELISA	N/A
Recruiting	`NCT04262492` - International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants
Withdrawn	`NCT00180778` - Steroids and Antiphospholipid Syndrome- Related Pregnancy Loss	Phase 1/Phase 2
Enrolling by invitation	`NCT05583305` - Prevalence and Etiologies of Intracranial Stenosis in Patients With Antiphospholipid Syndrome
Recruiting	`NCT05644210` - Telitacicept Followed With Rituximab Therapy on APS Secondary to SLE
Recruiting	`NCT02303171` - Use of Warfarin After the First Trimester in Pregnant Women With APS	Phase 4
Not yet recruiting	`NCT06420154` - The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune Diseases	Early Phase 1
Completed	`NCT00674297` - Effects of Fluvastatin on Proinflammatory and Prothrombotic Markers in Antiphospholipid Syndrome Patients	Phase 2
Recruiting	`NCT05859997` - Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases	N/A
Recruiting	`NCT06373003` - Negative Antiphospholipid Syndrome: a Multicentric Study
Recruiting	`NCT06373926` - Evaluation of Cell Membrane Expression of Annexin A2 on Monocytes by Flow Cytometry in Primary Antiphospholipid Syndrome	N/A
Recruiting	`NCT01818505` - The Influence of Antiphospholipid Antibodies on the Relationship Between Hyperurecemia, Gout and Metabolic Syndrome	N/A
Completed	`NCT00878137` - Reliability of Point-of-care INR Measurements in Patients With Antiphospholipid-antibody Syndrome Treated With Warfarin	N/A
Completed	`NCT01104337` - Drug Interaction Between Paracetamol and Warfarin	Phase 4